|
|
Volumn 2, Issue 5, 2001, Pages 431-436
|
|
Locally advanced and metastatic bladder cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
BLADDER TUMOR;
CANCER INVASION;
CARCINOMA;
CHRONIC KIDNEY FAILURE;
CYSTECTOMY;
EPIDEMIOLOGY;
FORECASTING;
HUMAN;
METASTASIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
REVIEW;
SURVIVAL RATE;
TRANSITIONAL CELL CARCINOMA;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
CYSTECTOMY;
EPIDEMIOLOGIC METHODS;
FORECASTING;
HUMANS;
KIDNEY FAILURE, CHRONIC;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
|
EID: 0035495693
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-001-0048-y Document Type: Review |
|
Times cited : (19)
|
|
References (28)
|
